Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124261743 | 12426174 | 3 | F | 20160515 | 20160829 | 20160601 | 20160901 | PER | US-PFIZER INC-2016284058 | PFIZER | 67.00 | YR | F | Y | 0.00000 | 20160901 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124261743 | 12426174 | 1 | PS | XELJANZ XR | TOFACITINIB CITRATE | 1 | 11 MG, 1X/DAY | U | N30256 | 208246 | 11 | MG | PROLONGED-RELEASE TABLET | QD | |||||
124261743 | 12426174 | 2 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | 2.5 MG, UNK | U | 11719 | 2.5 | MG | ||||||||
124261743 | 12426174 | 3 | SS | FOLIC ACID. | FOLIC ACID | 1 | 1 MG, UNK | U | 5897 | 1 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124261743 | 12426174 | 1 | Rheumatoid arthritis |
124261743 | 12426174 | 2 | Rheumatoid arthritis |
124261743 | 12426174 | 3 | Rheumatoid arthritis |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124261743 | 12426174 | Nasopharyngitis | |
124261743 | 12426174 | Paranasal sinus discomfort | |
124261743 | 12426174 | Sinus headache |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124261743 | 12426174 | 1 | 20160515 | 0 |